Title 31. HEALTH · Chapter 52. TERMINALLY ILL PATIENT’S RIGHT TO TRY INVESTIGATIONAL DRUGS, BIOLOGICAL PRODUCTS, AND DEVICES · Article 1. RIGHT TO TRY
31-52-6. Manufacturers permitted to make investigational drugs, biological products, or devices available.
Current through: Including Acts of the 2025 Session of the General Assembly of Georgia.
- (a)
A manufacturer of an investigational drug, biological product, or device may make available and an eligible patient may request access to the manufacturer’s investigational drug, biological product, or device pursuant to this article; provided, however, that nothing in this article shall be construed to require that a manufacturer make available an investigational drug, biological product, or device to an eligible patient.#
- (b)
A manufacturer may provide an investigational drug, biological product, or device to an eligible patient:#
History
Code 1981, § 31-52-6, enacted by Ga. L. 2016, p. 345, § 1/HB 34; Ga. L. 2025, p. 455, § 3/SB 72, effective July 1, 2025.
Amendments
The 2025 amendment, effective July 1, 2025, substituted “article” for “chapter” twice in subsection (a).
Editor's notes
Ga. L. 2025, p. 455, § 1/SB 72, not codified by the General Assembly, provides: “This Act shall be known and may be cited as the ‘Hope for Georgia Patients Act.’”
Read the official page (the state's PDF, opened at the page this text was read from).
Current through: Including Acts of the 2025 Session of the General Assembly of Georgia.
Text read from t31-(v23)-2025-pdf.pdf, Volume V23, 2025 edition, page 1090; merge action: bound only; file SHA-256 ba5a57f85d04.
Ask about this section
The answer is drawn from this section and, when they fit, the other sections of its chapter. It quotes the text and names the section for each claim. Not legal advice.